30
Participants
Start Date
November 30, 2021
Primary Completion Date
February 7, 2023
Study Completion Date
March 7, 2023
MHV370
MHV370 for 24 weeks
Placebo
Placebo for 24 weeks
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Székesfehérvár
Novartis Investigative Site, Berlin
Novartis Investigative Site, Madrid
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Changchun
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Lublin
Novartis Investigative Site, Warsaw
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY